ARS Pharmaceuticals Inc (NASDAQ:SPRY)

Delayed Data
As of 3:59pm ET
 -0.18 / -2.65%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +157.19% increase from the last price of 6.61.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in ARS Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.50%
Growthannually 9.96%


Growthquarterly -100.00%
Growthannually 496.45%
Key to the earnings and sales forecast charts.